Abstract: Agonist analogs of amylin and related pharmaceutical compositions, and methods of treatment of diabetes and other insulin-requiring states, as well as methods of treatment of hypoglycemia, are provided.
Type:
Grant
Filed:
December 6, 1999
Date of Patent:
August 26, 2003
Assignee:
Amylin Pharmaceuticals, Inc.
Inventors:
Laura S. L. Gaeta, Howard Jones, Elisabeth Albrecht